Literature DB >> 9196408

Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation.

R M Heppell1, K E Berkin, J M McLenachan, J A Davies.   

Abstract

OBJECTIVE: To evaluate the role of haemostatic and haemodynamic variables in left atrial thrombosis in non-rheumatic atrial fibrillation.
DESIGN: Case-control study.
SUBJECTS: One hundred and nine patients with non-rheumatic atrial fibrillation.
INTERVENTIONS: Peak blood velocity measured at three sites in the left atrium. Venous blood sampled for coagulant proteins and markers of haemostatic activation. MAIN OUTCOME MEASURES: Presence of left atrial thrombus and spontaneous echo contrast at transoesophageal echocardiography.
RESULTS: Left atrial thrombus was identified in 19 patients (18%), 16 of whom had spontaneous echo contrast. Patients with thrombus had reduced peak left atrial appendage velocity compared with those without (0.17 v 0.26 m/s; P < 0.001), but no significant reductions in peak mid-left atrial or mitral valve outflow velocity. Patients with thrombus had increased plasma markers of platelet activation-beta thromboglobulin (56.8 v 30.4 IU/ml; P < 0.001) and platelet factor 4 (6.1 v 3.5 IU/ml; P < 0.01)-and of thrombogenesis: thrombin-antithrombin complexes (5.59 v 3.06 micrograms/ml; P < 0.001) and D-dimers (479 v 298 ng/ml; P < 0.01). von Willebrand factor was also increased (1.81 v 1.52 IU/ml; P < 0.05). A multiple logistic regression model identified left atrial appendage velocity (P = 0.001), beta thromboglobulin (P = 0.002), and von Willebrand factor (P = 0.04) as the independent associates of left atrial thrombosis, ahead of the presence of spontaneous echo contrast.
CONCLUSIONS: Haemostatic and haemodynamic abnormalities are associated with left atrial thrombus in non-rheumatic atrial fibrillation, and may help stratify thromboembolic risk.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9196408      PMCID: PMC484760          DOI: 10.1136/hrt.77.5.407

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Increased intracardiovascular clotting in patients with chronic atrial fibrillation.

Authors:  K Kumagai; M Fukunami; M Ohmori; A Kitabatake; T Kamada; N Hoki
Journal:  J Am Coll Cardiol       Date:  1990-08       Impact factor: 24.094

2.  Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.

Authors:  C Gustafsson; M Blombäck; M Britton; A Hamsten; J Svensson
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

3.  [Detection of mural thrombi and analysis of blood flow velocities in the left atrial appendage using transesophageal two-dimensional echocardiography and pulsed Doppler flowmetry].

Authors:  M Suetsugu; M Matsuzaki; Y Toma; Y Anno; T Maeda; K Okada; M Konishi; S Ono; N Tanaka; J Hiro
Journal:  J Cardiol       Date:  1988-06       Impact factor: 3.159

4.  Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk.

Authors:  W G Daniel; U Nellessen; E Schröder; B Nonnast-Daniel; P Bednarski; P Nikutta; P R Lichtlen
Journal:  J Am Coll Cardiol       Date:  1988-06       Impact factor: 24.094

5.  Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus.

Authors:  W Aschenberg; M Schlüter; P Kremer; E Schröder; V Siglow; W Bleifeld
Journal:  J Am Coll Cardiol       Date:  1986-01       Impact factor: 24.094

6.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

7.  Enhanced in vivo platelet activation in subtypes of ischemic stroke.

Authors:  A B Shah; N Beamer; B M Coull
Journal:  Stroke       Date:  1985 Jul-Aug       Impact factor: 7.914

8.  Usefulness of the measurement of plasma beta-thromboglobulin (beta-TG) in cerebrovascular disease.

Authors:  K Taomoto; M Asada; Y Kanazawa; S Matsumoto
Journal:  Stroke       Date:  1983 Jul-Aug       Impact factor: 7.914

9.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

10.  Platelet function tests in thrombotic cerebrovascular disorders.

Authors:  S Uchiyama; M Takeuchi; M Osawa; I Kobayashi; S Maruyama; M Aosaki; K Hirosawa
Journal:  Stroke       Date:  1983 Jul-Aug       Impact factor: 7.914

View more
  34 in total

1.  [Persistent left atrial thrombus in atrial fibrillation under oral anticoagulation].

Authors:  B Leithäuser; F Kasch; T Broemel; J-W Park
Journal:  Herz       Date:  2010-12       Impact factor: 1.443

2.  Evaluation of left atrial appendage functions in patients with thrombus and spontaneous echo contrast in left atrial appendage by using color Doppler tissue imaging.

Authors:  Ramazan Topsakal; Namik Kemal Eryol; Yüksel Ciçek; Hayrettin Sağlam; Ergün Seyfeli; Adnan Abaci; Abdurrahman Oğuzhan; Ali Ergin; Emrullah Başar
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-10       Impact factor: 1.468

Review 3.  Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Negative D-dimer may allow safe early cardioversion of atrial fibrillation.

Authors:  Richard Body; Babak Allie
Journal:  Emerg Med J       Date:  2007-06       Impact factor: 2.740

4.  Relationship between spontaneous echo contrast in the thoracic aorta and plasma von Willebrand factor.

Authors:  Takuya Inoue; Makoto Suzuki; Atsushi Namiki; Hironori Hirai; Kaoru Sugi
Journal:  J Med Ultrason (2001)       Date:  2006-12-22       Impact factor: 1.314

5.  Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.

Authors:  G Y Lip
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

Review 6.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

7.  Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke.

Authors:  Azza A Eltayeb; Gamal A Askar; Naglaa H Abu Faddan; Taghreed M Kamal
Journal:  Ther Adv Neurol Disord       Date:  2015-03       Impact factor: 6.570

8.  Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation.

Authors:  Dmitry A Zateyshchikov; Alexey N Brovkin; Dimitry A Chistiakov; Valery V Nosikov
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

9.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

Review 10.  [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management].

Authors:  Jelena Kornej; Katja Schumacher; Daniela Husser; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.